WHO Classification of Tumours Editorial Board (2022) Central nervous system tumours. International Agency for Research on Cancer
Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO Classification of Tumors of the central nervous system: a summary. Neuro Oncol 23:1231–1251. https://doi.org/10.1093/neuonc/noab106
Article CAS PubMed PubMed Central Google Scholar
Eckel-Passow JE, Lachance DH, Molinaro AM et al (2015) Glioma Groups Based on 1p/19q, IDH, and tert Promoter Mutations in Tumors. N Engl J Med 372:2499–2508. https://doi.org/10.1056/NEJMoa1407279
Article CAS PubMed PubMed Central Google Scholar
Kaur G, Rana PS, Arora V (2022) State-of-the-art techniques using pre-operative brain MRI scans for survival prediction of glioblastoma multiforme patients and future research directions. Clin Transl Imaging 10:355–389. https://doi.org/10.1007/s40336-022-00487-8
Article PubMed PubMed Central Google Scholar
Islam M, Wijethilake N, Ren H (2021) Glioblastoma multiforme prognosis: MRI missing modality generation, segmentation and radiogenomic survival prediction. Comput Med Imaging Graph 91:101906. https://doi.org/10.1016/j.compmedimag.2021.101906
Wang B, Zhang S, Wu X et al (2021) Multiple survival outcome prediction of glioblastoma patients based on multiparametric MRI. Front Oncol 11:778627. https://doi.org/10.3389/fonc.2021.778627
Article PubMed PubMed Central Google Scholar
Ellingson BM, Kim HJ, Woodworth DC et al (2014) Recurrent glioblastoma treated with bevacizumab: contrast-enhanced T1-weighted subtraction maps improve tumor delineation and aid prediction of survival in a multicenter clinical trial. Radiology 271:200–210. https://doi.org/10.1148/radiol.13131305
Wangaryattawanich P, Hatami M, Wang J et al (2015) Multicenter imaging outcomes study of the Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival. Neuro Oncol 17:1525–1537. https://doi.org/10.1093/neuonc/nov117
Article PubMed PubMed Central Google Scholar
Gutman DA, Cooper LAD, Hwang SN et al (2013) MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set. Radiology 267:560–569. https://doi.org/10.1148/radiol.13120118
Article PubMed PubMed Central Google Scholar
Tatekawa H, Uetani H, Hagiwara A et al (2021) Preferential tumor localization in relation to 18F-FDOPA uptake for lower-grade gliomas. J Neurooncol 152:573–582. https://doi.org/10.1007/s11060-021-03730-w
Article CAS PubMed PubMed Central Google Scholar
Ellingson BM, Lai A, Harris RJ et al (2013) Probabilistic radiographic atlas of glioblastoma phenotypes. AJNR Am J Neuroradiol 34:533–540. https://doi.org/10.3174/ajnr.A3253
Article CAS PubMed PubMed Central Google Scholar
Fyllingen EH, Bø LE, Reinertsen I et al (2021) Survival of glioblastoma in relation to tumor location: a statistical tumor atlas of a population-based cohort. Acta Neurochir 163:1895–1905. https://doi.org/10.1007/s00701-021-04802-6
Roux A, Roca P, Edjlali M et al (2019) MRI atlas of IDH wild-type supratentorial glioblastoma: probabilistic maps of phenotype, management, and outcomes. Radiology 293:633–643. https://doi.org/10.1148/radiol.2019190491
Moons KGM, Altman DG, Reitsma JB et al (2015) Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med 162:W1-73. https://doi.org/10.7326/M14-0698
Calabrese E, Villanueva-Meyer JE, Rudie JD et al (2022) The University of California San Francisco preoperative diffuse glioma MRI dataset. Radiol Artif Intell 4:e220058. https://doi.org/10.1148/ryai.220058
Article PubMed PubMed Central Google Scholar
Bakas S, Sako C, Akbari H et al (2022) The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomics. Sci Data 9:453. https://doi.org/10.1038/s41597-022-01560-7
Article PubMed PubMed Central Google Scholar
Bakas S, Sako C, Akbari H et al (2022) Multi-parametric magnetic resonance imaging (mpMRI) scans for de novo Glioblastoma (GBM) patients from the University of Pennsylvania Health System. The Cancer Imaging Archive. https://doi.org/10.7937/TCIA.709X-DN49
Clark K, Vendt B, Smith K et al (2013) The Cancer Imaging Archive (TCIA): maintaining and operating a public information repository. J Digit Imaging 26:1045–1057. https://doi.org/10.1007/s10278-013-9622-7
Article PubMed PubMed Central Google Scholar
Calabrese E, Villanueva-Meyer J, Rudie J, et al (2022) The University of California, San Francisco preoperative diffuse glioma MRI . The Cancer Imaging Archive. https://doi.org/10.7937/tcia.bdgf-8v37
Adeberg S, Bostel T, König L et al (2014) A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival? Radiat Oncol 9:95. https://doi.org/10.1186/1748-717X-9-95
Article PubMed PubMed Central Google Scholar
Liu TT, Achrol AS, Mitchell LA et al (2016) Computational identification of tumor anatomic location associated with survival in 2 large cohorts of human primary glioblastomas. AJNR Am J Neuroradiol 37:621–628. https://doi.org/10.3174/ajnr.A4631
Article CAS PubMed PubMed Central Google Scholar
Mrugala MM (2013) Advances and challenges in the treatment of glioblastoma: a clinician’s perspective. Discov Med 15:221–230
Thust SC, Yousry T (2016) Imaging of skull base tumours. Rep Pract Oncol Radiother 21:304–318. https://doi.org/10.1016/j.rpor.2015.12.008
Article PubMed PubMed Central Google Scholar
Meyronet D, Esteban-Mader M, Bonnet C et al (2017) Characteristics of H3 K27M-mutant gliomas in adults. Neuro Oncol 19:1127–1134. https://doi.org/10.1093/neuonc/now274
Article CAS PubMed PubMed Central Google Scholar
Schreck KC, Ranjan S, Skorupan N et al (2019) Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically determined midline gliomas. J Neurooncol 143:87–93. https://doi.org/10.1007/s11060-019-03134-x
Article CAS PubMed PubMed Central Google Scholar
Sanai N, Alvarez-Buylla A, Berger MS (2005) Neural stem cells and the origin of gliomas. N Engl J Med 353:811–822. https://doi.org/10.1056/NEJMra043666
Article CAS PubMed Google Scholar
Weenink B, French PJ, Sillevis Smitt PAE et al (2020) Immunotherapy in glioblastoma: Current shortcomings and future perspectives. Cancers (Basel) 12:751. https://doi.org/10.3390/cancers12030751
Article CAS PubMed Google Scholar
Medikonda R, Dunn G, Rahman M et al (2021) A review of glioblastoma immunotherapy. J Neurooncol 151:41–53. https://doi.org/10.1007/s11060-020-03448-1
留言 (0)